Todisco Joseph 4
4 · CorMedix Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Todisco Joseph
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-18$4.43/sh+30,000$132,900→ 539,496 total - Sale
Common Stock
2025-12-18$12.00/sh−30,000$360,000→ 509,496 total - Exercise/Conversion
Stock Option (Right to Buy Common Stock)
2025-12-18−30,000→ 370,000 totalExercise: $4.43Exp: 2033-01-14→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $12.00 to $12.02, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]These options were granted on 01/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.